These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Metformin may reduce oral cancer risk in patients with type 2 diabetes. Tseng CH. Oncotarget; 2016 Jan 12; 7(2):2000-8. PubMed ID: 26683519 [Abstract] [Full Text] [Related]
10. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis. Tseng CH. Diabetes Metab; 2017 Oct 12; 43(5):438-445. PubMed ID: 28438547 [Abstract] [Full Text] [Related]
13. Metformin and risk of developing nasopharyngeal cancer in patients with type 2 diabetes mellitus. Tseng CH. Metabolism; 2018 Aug 12; 85():223-226. PubMed ID: 29729227 [Abstract] [Full Text] [Related]
14. Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus. Tseng CH. J Crohns Colitis; 2021 Jan 13; 15(1):64-73. PubMed ID: 32604412 [Abstract] [Full Text] [Related]
17. Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes. Tseng CH. Breast Cancer Res Treat; 2014 Jun 13; 145(3):785-90. PubMed ID: 24816805 [Abstract] [Full Text] [Related]
18. Metformin reduces risk of varicose veins in patients with type 2 diabetes. Tseng CH. Diabetes Metab Res Rev; 2020 Feb 13; 36(2):e3206. PubMed ID: 31322821 [Abstract] [Full Text] [Related]
19. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study. Ou HT, Chang KC, Li CY, Wu JS. Cardiovasc Diabetol; 2016 Mar 01; 15():41. PubMed ID: 26932742 [Abstract] [Full Text] [Related]